Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

T Cells Armed With Chimeric Antigen Receptor Recognizing EpCAM for Patients With Advanced Solid Tumors

NCT02915445 is registered in ClinicalTrials.gov with Sichuan University as lead sponsor.

NCT NCT02915445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02915445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
T Cells Armed With Chimeric Antigen Receptor Recognizing EpCAM for Patients With Advanced Solid Tumors
Lead sponsor
Sichuan University
Phase
Phase 1
Overall status
Unknown status
Start date
July 31, 2016
Completion date
July 31, 2025
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer recurrent, gastric cancer with metastasis, malignant neoplasm of nasopharynx tnm staging distant metastasis (m)